| 1 |
35237910 | Value of stimulated pre-ablation thyroglobulin as a prognostic marker in patients with differentiated thyroid carcinoma treated with radioiodine. | 2022 Jun |
1 |
| 2 |
34040584 | Predictive Value of Thyroglobulin Changes for the Curative Effect of Radioiodine Therapy in Patients With Metastatic Differentiated Thyroid Carcinoma. | 2021 |
1 |
| 3 |
34941104 | Pregnancy exacerbated lymph node metastasis of well differentiated thyroid carcinoma: A case report. | 2021 Dec 23 |
1 |
| 4 |
31352718 | The clinical meaning of pre- and post-ablation thyroglobulin levels at first radioiodine therapy in patients with papillary thyroid cancer. | 2020 Sep |
1 |
| 5 |
32219303 | Detecting Recurrence Following Lobectomy for Thyroid Cancer: Role of Thyroglobulin and Thyroglobulin Antibodies. | 2020 Jun 1 |
1 |
| 6 |
30560716 | Radioiodine Uptake and Thyroglobulin-Guided Radioiodine Remnant Ablation in Patients with Differentiated Thyroid Cancer: A Prospective, Randomized, Open-Label, Controlled Trial. | 2019 Jan |
1 |
| 7 |
30930852 | Outcome of Patients With Differentiated Thyroid Cancer Treated With 131-Iodine on the Basis of a Detectable Serum Thyroglobulin Level After Initial Treatment. | 2019 |
2 |
| 8 |
31327159 | Unusual metastases from differentiated thyroid carcinoma: analysis of 36 cases. | 2019 Sep |
2 |
| 9 |
31363334 | DIFFERENTIATED THYROID CANCER IN PEDIATRIC POPULATION (≤18 YEARS): POSTOPERATIVE TREATMENT WITH RADIOACTIVE IODINE (I-131). | 2019 Mar |
1 |
| 10 |
29665748 | Low or Undetectable Basal Thyroglobulin Levels Obviate the Need for Neck Ultrasound in Differentiated Thyroid Cancer Patients After Total Thyroidectomy and 131I Ablation. | 2018 Jun |
1 |
| 11 |
29860933 | Changing Trend of Thyroglobulin Antibodies in Patients With Differentiated Thyroid Cancer Treated With Total Thyroidectomy Without 131I Ablation. | 2018 Jul |
2 |
| 12 |
30283740 | Prognostic Value of Stimulated Thyroglobulin Levels at the Time of Radioiodine Administration in Differentiated Thyroid Cancer. | 2018 Aug |
1 |
| 13 |
27144920 | Thyroglobulin levels and thyroglobulin/thyrotropin ratio could predict the success of the ablative/therapeutic 131I in the differentiated thyroid cancers. | 2017 Feb |
2 |
| 14 |
27909769 | Evaluation of 131I scintigraphy and stimulated thyroglobulin levels in the follow up of patients with DTC: a retrospective analysis of 1420 patients. | 2017 May |
1 |
| 15 |
27929713 | Postoperative Thyroglobulin and Neck Ultrasound in the Risk Restratification and Decision to Perform 131I Ablation. | 2017 Mar 1 |
1 |
| 16 |
28076008 | Pictorial Review of False-Positive Results on Radioiodine Scintigrams of Patients with Differentiated Thyroid Cancer. | 2017 Jan-Feb |
1 |
| 17 |
28482079 | Letter to the Editor: "Postoperative Thyroglobulin and Neck Ultrasound in the Risk Restratification and Decision to Perform 131I Ablation". | 2017 May 1 |
1 |
| 18 |
28482084 | Response to Letter: "Postoperative Thyroglobulin and Neck Ultrasound in the Risk Restratification and Decision to Perform 131I Ablation". | 2017 May 1 |
1 |
| 19 |
28505591 | Factors associated with serum thyroglobulin in a Ukrainian cohort exposed to iodine-131 from the accident at the Chernobyl Nuclear Plant. | 2017 Jul |
1 |
| 20 |
28543974 | Neck Sonography and Suppressed Thyroglobulin Have High Sensitivity for Identifying Recurrent/Persistent Disease in Patients With Low-risk Thyroid Cancer Treated With Total Thyroidectomy and Radioactive Iodine Ablation, Making Stimulated Thyroglobulin Unnecessary. | 2017 Nov |
1 |
| 21 |
28688088 | Early stimulated thyroglobulin for response prediction after recombinant human thyrotropin-aided radioiodine therapy. | 2017 Oct |
2 |
| 22 |
26668060 | Papillary thyroid carcinomas with biochemical incomplete or indeterminate responses to initial treatment: repeat stimulated thyroglobulin assay to identify disease-free patients. | 2016 Nov |
2 |
| 23 |
26801644 | Low postoperative nonstimulated thyroglobulin as a criterion for the indication of low radioiodine activity in patients with papillary thyroid cancer of intermediate risk 'with higher risk features'. | 2016 Sep |
1 |
| 24 |
26884109 | Ongoing risk stratification for differentiated thyroid cancer (DTC) - stimulated serum thyroglobulin (Tg) before radioiodine (RAI) ablation, the most potent risk factor of cancer recurrence in M0 patients. | 2016 |
1 |
| 25 |
27034856 | A Case Report of Dramatically Increased Thyroglobulin after Lymph Node Biopsy in Thyroid Carcinoma after Total Thyroidectomy and Radioiodine. | 2016 |
3 |
| 26 |
27751976 | Aggressive Disease Course of Papillary Thyroid Carcinoma with Focal Undifferentiated Component: A Case Report. | 2016 Oct 5 |
3 |
| 27 |
28856198 | Evaluation of the highly sensitive Roche thyroglobulin II assay and establishment of a reference limit for thyroglobulin-negative patient samples. | 2016 Aug 1 |
1 |
| 28 |
25205448 | Adjuvant therapy with 131-iodine in patients with elevated serum thyroglobulin after reoperation due to papillary thyroid carcinoma lymph node metastases. | 2015 May |
1 |
| 29 |
25393656 | A low postoperative nonstimulated serum thyroglobulin level excludes the presence of persistent disease in low-risk papillary thyroid cancer patients: implication for radioiodine indication. | 2015 Dec |
1 |
| 30 |
25404419 | Serum thyroglobulin level after radioiodine therapy (Day 3) to predict successful ablation of thyroid remnant in postoperative thyroid cancer. | 2015 Feb |
1 |
| 31 |
25546193 | Thyroglobulin flare response after radioiodine ablation in 2 patients with differentiated thyroid cancer. | 2015 May |
5 |
| 32 |
25724214 | Characteristics and prognosis of patients with thyroglobulin-positive and radioactive iodine whole-body scan-negative differentiated thyroid carcinoma. | 2015 May |
1 |
| 33 |
25763842 | Serum Thyroglobulin Measured With a Second-Generation Assay in Patients Undergoing Total Thyroidectomy Without Radioiodine Remnant Ablation: A Prospective Study. | 2015 Jul |
1 |
| 34 |
25881600 | Postoperative stimulated thyroglobulin level and recurrence risk stratification in differentiated thyroid cancer. | 2015 Apr 20 |
1 |
| 35 |
25895485 | Transient early increase in thyroglobulin levels post-radioiodine ablation in patients with differentiated thyroid cancer. | 2015 Jul |
1 |
| 36 |
25980591 | Prediction of treatment response to ¹³¹I therapy by diffuse hepatic uptake intensity on post-therapy whole-body scan in patients with distant metastases of differentiated thyroid cancer. | 2015 Aug |
1 |
| 37 |
26458613 | Thymus uptake of 131I in patients with differentiated thyroid carcinoma: Three different case scenarios and patterns of uptake and the importance of its recognition in thyroid cancer practice. | 2015 Jul-Sep |
1 |
| 38 |
26550046 | Correlation of Consecutive Serum Thyroglobulin Levels During Hormone Withdrawal and Failure of Initial Radioiodine Ablation in Thyroid Cancer Patients. | 2015 Dec |
5 |
| 39 |
23826916 | Thyroglobulin as early prognostic marker to predict remission at 18-24 months in differentiated thyroid carcinoma. | 2014 Feb |
1 |
| 40 |
24385210 | Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin. | 2014 May |
2 |
| 41 |
24761858 | Importance of postoperative stimulated thyroglobulin level at the time of 131I ablation therapy for differentiated thyroid cancer. | 2014 |
3 |
| 42 |
24820222 | Do negative 124I pretherapy positron emission tomography scans in patients with elevated serum thyroglobulin levels predict negative 131I posttherapy scans? | 2014 Sep |
1 |
| 43 |
24866576 | Stimulated thyroglobulin level at ablation in differentiated thyroid cancer: the impact of treatment preparation modalities and tumor burden. | 2014 Aug |
4 |
| 44 |
25988151 | Differentiated thyroid cancer in patients with resistance to thyroid hormone syndrome. A novel case and a review of the literature. | 2014 |
1 |
| 45 |
23190420 | Factors associated with serum thyroglobulin levels in a population living in Belarus. | 2013 Jul |
1 |
| 46 |
23489940 | Postoperative-stimulated serum thyroglobulin measured at the time of 131I ablation is useful for the prediction of disease status in patients with differentiated thyroid carcinoma. | 2013 Jun |
1 |
| 47 |
23567283 | Sustained and diffuse 131I avid bone metastases with low thyroglobulin levels in a patient with papillary thyroid carcinoma. | 2013 May |
1 |
| 48 |
24037891 | Stimulated thyroglobulin at recombinant human TSH-aided ablation predicts disease-free status one year later. | 2013 Nov |
1 |
| 49 |
21971605 | Diagnostic accuracy of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in differentiated thyroid cancer patients with elevated thyroglobulin and negative (131)I whole body scan: evaluation by thyroglobulin level. | 2012 Jan |
1 |
| 50 |
22498723 | Combining transfer of TTF-1 and Pax-8 gene: a potential strategy to promote radioiodine therapy of thyroid carcinoma. | 2012 Jun |
4 |